Table 5.
CoV-P2 CXR features | Number of cases | % |
---|---|---|
Pattern | ||
GGO | 15 | 34% |
Consolidation | 6 | 14% |
Mixed | 23 | 52% |
Lung involvement | ||
Unilateral | 0 | 0% |
Bilateral | 44 | 100% |
Vertical distribution | ||
Lower predominant | 33 | 75% |
Upper predominant | 0 | 0% |
Diffuse involvement | 11 | 25% |
Transverse distribution | ||
Peripheral | 0 | 0% |
Perihilar | 0 | 0% |
No predilection | 44 | 100% |
Peripheral consolidation | 20 | 45% |
(GGO = Ground Glass Opacities)